Multi-Nutrients 5 (Boron Copper and Iron Free)
Product analysis
Multi-Nutrients 5 (Boron Copper and Iron Free) offers broad nutritional support for people seeking a formula without those three minerals. Its main value is filling dietary gaps relevant to skin, vision and normal blood-vessel function.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality36
Natural-form vitamin E is a clear quality strength, while many other named forms lack enough detail for a confident quality judgment. Several forms are also unspecified, making the quality picture incomplete.
Ingredient Transparency93
All listed amounts and most forms are disclosed, including the vitamin A mixture composition. Five forms remain unspecified, and differing B6 declarations leave its total uncertain.
Value For Money42
Vitamin A offers favorable value, and vitamin E compares reasonably at the full serving cost. Value from most other nutrients remains uncertain, leaving the complete formula harder to judge.
Customer Satisfaction70
Customer ratings are favorable, but the review base is limited. The small sample leaves less certainty about the wider customer experience.
Product Focus35
The broad nutrient range mainly supports normal functions when intake is low. Its more specific skin, eye and cardiovascular uses remain qualified, with no established added benefits once nutrient needs are met.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $0.69
- Customer rating
- 4.7 · 23 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin A (Beta-Carotene, Mixed Carotenoids, Vitamin A Acetate) | 8750 IU | |
Vitamin C | 125 mg | |
Vitamin D3 (Cholecalciferol) | 400 IU | |
Vitamin E (D-Alpha-Tocopheryl Succinate) | 150 IU | |
Thiamine (Thiamine Hydrochloride) | 12.5 mg | |
Riboflavin | 12.5 mg | |
Vitamin B6 (Pyridoxine Hydrochloride) | 12.5 mg | |
Folate (L-5-MTHF) | 100 mcg | |
Vitamin B12 (Methylcobalamin) | 500 mcg | |
Biotin | 150 mcg | |
Pantothenic Acid (Calcium Pantothenate) | 50 mg | |
Calcium (Dicalcium Malate) | 125 mg | |
Iodine (Potassium Iodide) | 75 mcg | |
Magnesium (DiMagnesium Malate) | 100 mg | |
Zinc (Zinc Citrate) | 15 mg | |
Selenium (Selenomethionine) | 200 mcg | |
Manganese (Manganese Citrate) | 2.5 mg | |
Chromium (Chromium Polynicotinate) | 100 mcg | |
Molybdenum (Molybdenum Aspartate) | 50 mcg | |
Niacinamide | 50 mg | |
Pyridoxal 5-Phosphate | 2.5 mg | |
Vanadium (Vanadium Citrate) | 5 mcg | |
Quercetin Dihydrate | 50 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability47
Vitamin A Chemical Form & Source
Dose, Safety & Label Transparency66
Dosage Efficacy & Safety Thresholds
Label Transparency of Specific Forms
Value80
Price per 5,000 IU Dose
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Associations of dietary folate, vitamin B6 and B12 intake with cardiovascular outcomes in 115664 participants: a large UK population-based cohort.
- Folate, Homocysteine, and Adverse Outcomes After Ischemic Stroke.
- Effect of folic acid on endothelial function following acute myocardial infarction.
- Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
- 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia.
- Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies.
- Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies.
- Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies.
- Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
- Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
- The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
- Effects of niacin on apo A1 and B levels: a systematic review and meta-analysis of randomised controlled trials.
- Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials.
- Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
- Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.
- Effect of supplementation with high-selenium yeast on plasma lipids: a randomized trial.
- Association of selenium and cadmium with heart failure and mortality based on the National Health and Nutrition Examination Survey.
- Higher serum selenium concentration is associated with lower risk of all-cause and cardiovascular mortality among individuals with chronic kidney disease: A population-based cohort study of NHANES.
- Selenium status in the body and cardiovascular disease: a systematic review and meta-analysis.
- Associations of selenium status with all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies.